The Drug Regulatory Authority of Pakistan (DRAP) has unveiled a report highlighting a significant 34 percent increase in ...
As a result of this change, IGC Pharma will file a transition report on Form 10-K with the U.S. Securities and Exchange Commission (the "SEC") covering the nine-month period from April 1, 2025, ...
New government legislation is needed to ensure full transparency of payments made by pharmaceutical companies to UK healthcare professionals and organisations to protect patient safety and public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback